logo-loader

Buds & Duds: Cannabis stocks climb; Canntab shares soar on hemp-cultivation licence

Published: 16:29 21 May 2019 EDT

Buds of the day are Canntab Therapeutics Ltd (CSE:PILL.CN) (OTCMKTS:CTABF), PreveCeutical Medical Inc (CSE:PREV) (OTCMKTS:PRVCF). The duds are The Supreme Cannabis Company Inc (TSE:FIRE) (OTCMKTS:SPRWF), BlissCo Cannabis Corp (CSE:BLIS). 

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

9 minutes ago